Cancer Management and Research
Volume 2, 2010 - Issue
Open access
43
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
Joseph Tripodi1 The Myeloproliferative Disorders Program, Tisch Cancer Institute, Department of Medicine and
, Ronald Hoffman1 The Myeloproliferative Disorders Program, Tisch Cancer Institute, Department of Medicine and
, Vesna Najfeld2 Department of Medicine and Pathology, Mount Sinai School of MedicineCorrespondence[email protected]
& Rona Weinberg3 The Myeloproliferative Disorders Program, Cellular Therapy Laboratory, The New York Blood Center, New York, NY, USA
Pages 219-223
|
Published online: 30 Sep 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.